SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001319244-15-000042
Filing Date
2015-09-25
Accepted
2015-09-25 17:02:55
Documents
1
Group Members
ICS OPPORTUNITIES, LTD.INTEGRATED ASSETS II LLCINTEGRATED ASSETS, LTD.INTEGRATED CORE STRATEGIES (US) LLCISRAEL A. ENGLANDERMILLENNIUM INTERNATIONAL MANAGEMENT GP LLCMILLENNIUM INTERNATIONAL MANAGEMENT LPMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 AERI_SC13G.htm SC 13G 155218
  Complete submission text file 0001319244-15-000042.txt   157312
Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103
Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103 (212) 841-4100
INTEGRATED CORE STRATEGIES (US) LLC (Filed by) CIK: 0001319244 (see all company filings)

IRS No.: 202196675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Subject) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87680 | Film No.: 151125699
SIC: 2836 Biological Products, (No Diagnostic Substances)